POKO
Azelaic Acid Spot Gel 30ml
Azelaic Acid Spot Gel 30ml
A targeted gel that effectively clarifies and minimises the appearance of breakouts.
This Spot Gel combines azelaic acid with the strength of vitamin A to encourage clearer skin and a healthy microbiome by unclogging the pores.
Share
Ingredients
Ingredients
Aqua, potassium azeloyl diglycinate, polyacrylate crosspolymer-6, cannabidiol (500mg), vitamin A (retinyl palmitate), phenoxyethanol.
Active Ingredients:
Azelaic acid renews, calms, and brightens spots making them less noticeable
Vitamin A encourages quicker cell turnover making the formation of new spots more difficult
How to use
How to use
Starting with a prepped base, apply after Poko's Soothing Serum for best results morning and evening. Massage the gel on to specific problem areas for targeted results. Product can also be gently applied to the entire face, avoiding the eyes and mouth. To lock in the product, follow with the Light Hydrating Moisturiser.
*With starting any new active skincare regime, a patch test prior to application is recommended.
Information
Information
Antioxidant, anti-bacterial, anti-inflammatory
With just 5 ingredients, including a water-soluble azelaic acid and retinol, our Azelaic Acid Spot Gel reduces the production of bacteria that can often lead to breakouts. Use as a remedy at the first signs of a breakout while preventing further spots from occurring.
Results without the harshness
Our natural Spot Gel is a no-fuss formula that protects the integrity of your skin's condition while minimising the appearance of spots with simple, trusted science. It's all natural formula reduces irritation and promotes healing. Targeted for specific areas of the skin that need encouragement to cleanse and heal.
For clogged pores due to keratin buildup
Keratin, a skin protein, can build up leading to clogged pores and ultimately breakouts. Blocked pores also lead to dull skin with unwanted texture and blemishes. People often find this is not due to how often they wash their face but commonly is due to a lack of targeted high-quality actives.